Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemisinin-based combination therapy trial for uncomplicated falciparum malaria
PACTR201803003018369Completed
- Sponsor
- Laboratorios Salvat
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of artemether + lumefantrine in Malaria (2 arms), sponsored by Laboratorios Salvat. Primary endpoint: Adequate Clinical and Parasitological Response. Started Sep 2013; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR201803003018369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201803003018369.